IS5663A - Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP - Google Patents

Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP

Info

Publication number: IS5663A
Authority: IS; Iceland
Prior art keywords: carnitine; nadhp; nadh; alkanoyl; composition
Prior art date: 1998-04-17

Application number

IS5663A

Other languages

English (en)

Inventor

Cavazza Claudio

Original Assignee

Sigma-Tau Healthscience S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-17

Filing date

2000-10-13

Publication date

2000-10-13

2000-10-13 Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.

2000-10-13 Publication of IS5663A publication Critical patent/IS5663A/is

Links

PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title 1
-1 alkanoyl L-carnitine Chemical compound 0.000 title 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 title 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Molecular Biology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS5663A 1998-04-17 2000-10-13 Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP IS5663A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT98RM000238A IT1299161B1 (it)	1998-04-17	1998-04-17	Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PCT/IT1999/000088 WO1999053921A1 (en)	1998-04-17	1999-04-14	Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (1)

Publication Number	Publication Date
IS5663A true IS5663A (is)	2000-10-13

Family

ID=11405812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5663A IS5663A (is)	1998-04-17	2000-10-13	Samsetning sem samanstendur af L-karnitíni eða alkanóýl L-karnitíni og NADH og/eða NADHP

Country Status (17)

Country	Link
EP (1)	EP1071424A1 (is)
JP (1)	JP2002512191A (is)
KR (1)	KR20010042765A (is)
CN (1)	CN1299283A (is)
AU (1)	AU750645B2 (is)
BR (1)	BR9909712A (is)
CA (1)	CA2328331A1 (is)
EE (1)	EE200000601A (is)
HU (1)	HUP0101914A3 (is)
IL (1)	IL139014A0 (is)
IS (1)	IS5663A (is)
IT (1)	IT1299161B1 (is)
NO (1)	NO20005128L (is)
PL (1)	PL343482A1 (is)
SK (1)	SK15442000A3 (is)
TR (1)	TR200002894T2 (is)
WO (1)	WO1999053921A1 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8252309B2 (en)	2000-04-04	2012-08-28	Sigma-Tau Industrie Farmaceutiche Riunite Spa	Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) *	2003-06-11	2005-01-05	Herzpharma Vita-Check Diagnosegeräte GmbH	Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
CN101677912B (zh) *	2007-05-11	2013-06-12	希格马托制药工业公司	可用于递送化妆品活性成分的凝胶
AU2010286348A1 (en) *	2009-08-31	2012-03-22	University Of South Australia	Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) *	2014-10-23	2015-01-28	苏州人本药业有限公司	还原型辅酶ⅱ的用途
CN104840479A (zh) *	2015-02-17	2015-08-19	苏州人本药业有限公司	Nadph在制备治疗心脏疾病药物中的应用
US10894059B2 (en)	2017-12-22	2021-01-19	Bontac Bio-Engineering (Shenzhen) Co., Ltd	NADH compound composition, and preparation and use thereof
EP3755160B1 (de)	2018-04-20	2021-11-03	Pacotrade AG	Vorrichtung zum zerkleinern von in blockform bereitgestellten tiefgefrorenen lebensmitteln
CN109105702A (zh) *	2018-08-30	2019-01-01	泓博元生命科技（深圳）有限公司	一种含有nadh的组合物、应用及能量补充剂的制备方法
CN109170907A (zh) *	2018-08-30	2019-01-11	泓博元生命科技（深圳）有限公司	一种含有nmn的组合物、应用及运动饮料的制备方法
AU2019357838A1 (en) *	2018-10-10	2021-04-15	So Ngor Sally LEUNG	Health product composition for supplementing deficiency, preparation method therefor and application thereof
CN117958433A (zh) *	2024-03-22	2024-05-03	四川新渔新美健康科技有限公司	不含咖啡因的抗疲劳功能组合物、饮料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1054698A (is) *	1964-12-04
US5292538A (en) *	1992-07-22	1994-03-08	Metagenics, Inc.	Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) *	1993-10-19	1995-04-20	Schleicher Peter	Geriatrikum
JPH09110708A (ja) *	1995-08-11	1997-04-28	Taisho Pharmaceut Co Ltd	滋養強壮用生薬配合製剤
JPH0959161A (ja) *	1995-08-23	1997-03-04	Taisho Pharmaceut Co Ltd	疲労改善用組成物
IT1277953B1 (it) *	1995-12-21	1997-11-12	Sigma Tau Ind Farmaceuti	Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) *	1996-03-15	1998-05-07	Mendes Srl	Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) *	1996-04-22	1998-01-27	Birkmayer Pharmaceuticals	NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) *	1996-04-25	2000-06-20	Abbott Laboratories	Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) *	1996-10-14	1998-06-30	Taisho Pharmaceut Co Ltd	疲労改善剤

1998
- 1998-04-17 IT IT98RM000238A patent/IT1299161B1/it active IP Right Grant
1999
- 1999-04-14 BR BR9909712-5A patent/BR9909712A/pt not_active IP Right Cessation
- 1999-04-14 WO PCT/IT1999/000088 patent/WO1999053921A1/en not_active Ceased
- 1999-04-14 EP EP99916039A patent/EP1071424A1/en not_active Withdrawn
- 1999-04-14 JP JP2000544325A patent/JP2002512191A/ja active Pending
- 1999-04-14 PL PL99343482A patent/PL343482A1/xx not_active Application Discontinuation
- 1999-04-14 AU AU34428/99A patent/AU750645B2/en not_active Ceased
- 1999-04-14 EE EEP200000601A patent/EE200000601A/xx unknown
- 1999-04-14 KR KR1020007011499A patent/KR20010042765A/ko not_active Withdrawn
- 1999-04-14 TR TR2000/02894T patent/TR200002894T2/xx unknown
- 1999-04-14 HU HU0101914A patent/HUP0101914A3/hu unknown
- 1999-04-14 CA CA002328331A patent/CA2328331A1/en not_active Abandoned
- 1999-04-14 IL IL13901499A patent/IL139014A0/xx unknown
- 1999-04-14 SK SK1544-2000A patent/SK15442000A3/sk unknown
- 1999-04-14 CN CN99805644A patent/CN1299283A/zh active Pending
2000
- 2000-10-12 NO NO20005128A patent/NO20005128L/no not_active Application Discontinuation
- 2000-10-13 IS IS5663A patent/IS5663A/is unknown

Also Published As

Publication number	Publication date
CA2328331A1 (en)	1999-10-28
AU3442899A (en)	1999-11-08
JP2002512191A (ja)	2002-04-23
TR200002894T2 (tr)	2001-01-22
IL139014A0 (en)	2001-11-25
SK15442000A3 (sk)	2001-06-11
EP1071424A1 (en)	2001-01-31
BR9909712A (pt)	2000-12-26
ITRM980238A1 (it)	1999-10-17
WO1999053921A1 (en)	1999-10-28
ITRM980238A0 (it)	1998-04-17
KR20010042765A (ko)	2001-05-25
NO20005128D0 (no)	2000-10-12
HUP0101914A2 (hu)	2002-03-28
EE200000601A (et)	2002-04-15
AU750645B2 (en)	2002-07-25
NO20005128L (no)	2000-12-18
PL343482A1 (en)	2001-08-27
HUP0101914A3 (en)	2002-12-28
IT1299161B1 (it)	2000-02-29
CN1299283A (zh)	2001-06-13

Publication	Publication Date	Title
DE69933825D1 (de)	2006-12-14	Chemisch verstärkte Positivresistzusammensetzung
DE69905371D1 (de)	2003-03-20	Härtbare zusammensetzung
IS5850A (is)	2001-02-16	Andoxunar samsetning sem samanstendur af asetýl L-karnitíni og alfa-lípósýru
SG79263A1 (en)	2001-03-20	Adhesive composition and adhesive sheet
GB9812413D0 (en)	1998-08-05	Compound and its use
HUP0104270A3 (en)	2002-04-29	Herbicidal composition and use thereof
EP0989459A4 (en)	2001-09-19	CHEMICALLY AMPLIFIED PROTECTIVE AGENT COMPOSITION
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
NO20022334L (no)	2002-07-09	Ny sammensetning og anvendelse
IL128869A0 (en)	2000-01-31	Pyrozolopyrimidines and pyrazolotriazines
DE69831605T2 (de)	2006-06-14	Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
DK1112003T3 (da)	2003-08-04	Ny sammensætning og anvendelse
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
DE69908455D1 (de)	2003-07-10	Kuvertiervorrichtung
IL138178A0 (en)	2001-10-31	Identifiable marking compositions and methods
GB2341692B (en)	2000-09-20	Resist composition
GB9817235D0 (en)	1998-10-07	Compound,composition and use
EP1056455A4 (en)	2000-12-06	EPIMORPHIN COMPOUND AND USE OF THE SAME
EE200000601A (et)	2002-04-15	L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon
NO20012973L (no)	2001-06-15	Polyester-polyuretanlim og anvendelsen derav
GB9817236D0 (en)	1998-10-07	Compound,composition and use
MA26666A1 (fr)	2004-12-20	Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
NO20006626D0 (no)	2000-12-22	Beleggingsmiddel og anvendelse herav
GB9903447D0 (en)	1999-04-07	Compound, composition and use
AU138508S (en)	1999-10-12	A flashlight